Gilead Sciences Derivative Contract Liabilities (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

149.41 +0.46 (+0.31%) USD | NASDAQ | Mar 02, 10:13

View Derivative Contract Liabilities (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Derivative Contract Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Derivative Contract Liabilities (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Johnson & Johnson	--
Regeneron Pharmaceuticals, Inc.	--
Arcellx, Inc.	--
Moderna, Inc.	--